Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)
Cancer - United States
doi 10.1002/cncr.30537
Full Text
Open PDFAbstract
Available in full text
Date
January 19, 2017
Authors
Publisher
Wiley